Title:
医薬組成物及びその応用
Document Type and Number:
Japanese Patent JP6633744
Kind Code:
B2
Abstract:
Disclosed are a pharmaceutical composition and an application thereof. The pharmaceutical composition includes one or more of a benzoheterocyclic compound as shown in formula (I), a pharmaceutically acceptable salt thereof, a solvate thereof, a crystalline form thereof, a co-crystal thereof, a stereoisomer thereof, an isotope compound thereof, a metabolite thereof and a prodrug thereof, and an androgen receptor pathway modulator. The pharmaceutical composition better inhibits prostate cancer cell growth.
More Like This:
Inventors:
Jae Shan Shen
Liao Bason
Rewen Shan
Liao Bason
Rewen Shan
Application Number:
JP2018517275A
Publication Date:
January 22, 2020
Filing Date:
September 28, 2016
Export Citation:
Assignee:
Kung by Offer Mathewicals Limited
International Classes:
A61K31/454; A61K31/41; A61K31/4155; A61K31/4439; A61K31/517; A61K31/5377; A61K31/573; A61K31/58; A61P13/08; A61P35/00; A61P43/00
Domestic Patent References:
| JP2012502038A | ||||
| JP2015117185A |
Foreign References:
| US20030045552 | ||||
| US20110196150 | ||||
| US20150080419 | ||||
| US20120071554 |
Other References:
Endocrine-Related Cancer,2015年 6月 1日,Vol.22,p.R87-R106
Attorney, Agent or Firm:
Nagoya International Patent Service Corporation